Neuroscience
-
Personalized TMS Shows Promise for Severe OCD in Singapore Study
NUH and NUS Medicine report early success using fMRI-guided stimulation for treatment-resistant OCD, aiming to extend the method to depression and anxiety.
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Alzheimer’s Amyloid Beta Explained: How Plaques Form and Two New Blood Tests Detect Them
NEW YORK, July 16 — For the millions of families touched by Alzheimer’s disease, the science can feel impossibly distant. But behind…
-
Brain Imaging Shows 8% Lower Choline in Anxiety Patients
ISLAMABAD, July 10 — New brain imaging research has uncovered a measurable link between anxiety disorders and lower levels of key nutrients…
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992
LONDON, July 10 — John Hardy, the British geneticist and neuroscientist who first proposed that amyloid-beta accumulation is the primary cause of…
-
Alzheimer’s Drug Lecanemab Slows Cognitive Decline 27% in Trial
MANILA, July 10 — For millions of families across Asia and around the world, the shadow of Alzheimer’s disease has long been…
-
Alois Alzheimer Identified Disease But Colleague Named It
BERLIN, July 8 — On the surface, the story of Alois Alzheimer is a straightforward tale of medical discovery. A German psychiatrist…
-
Two Antibody Drugs Now Slow Early Alzheimer’s Decline, With Brain-Swelling Risks
WASHINGTON — For the millions of American families touched by Alzheimer’s disease, the past few years have brought something that once felt…
-
Modified Vitamin B12 Crosses Blood-Brain Barrier and Targets Glioblastoma in Animal Study
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
-
Modified B12 compound with nitric oxide targets glioblastoma in animal tests
Glioblastoma patients have a grim clock. Median survival: under 15 months. Even with surgery, radiation, and chemotherapy, the tumor almost always returns.…
-
What’s Actually Driving Your Chronic Pain, From A Pain Psychologist
NEW YORK, June 28 — For nearly two decades, a psychologist who specializes in pain has been living with a reminder that…
-
Less Than 42 Minutes of Bright Daylight a Day Linked to Higher Dementia Risk
The latest study out of China, published in the journal General Psychiatry, lands in a country where nearly a million people already…
-
Cleveland study finds vitamin B12 compound may cross blood-brain barrier to treat glioblastoma
CLEVELAND — Fifteen months. That is the average survival time for a patient diagnosed with glioblastoma. Surgery, radiation, chemotherapy — standard care…
-
Brain Changes Precede Alzheimer’s Plaques by Years, and Memory Awareness Fades Before Dementia
The clock on dementia starts ticking long before the first forgotten name. New research confirms what many in the longevity field have…
-
Kindai University Study: Arginine Cut Alzheimer’s-Linked Amyloid in Mice and Flies
A cheap, widely available dietary supplement may have just given Alzheimer’s research a jolt. Japanese scientists report that arginine, a common amino…
-
Oral Arginine Cuts Amyloid Buildup in Fly and Mouse Models of Alzheimer’s
TOKYO, June 6, 2026 — infopulsetoday.com — Researchers in Japan have made a promising discovery in the fight against Alzheimer’s disease, reporting…
-
Scientists Find Molecular Switch Locking Alzheimer’s Inflammation On
LA JOLLA, June 5 — Researchers at Scripps Research have made a significant discovery in understanding the molecular mechanism behind the chronic…
-
Scripps Research Finds STING Protein Fuels Alzheimer’s Inflammation
LA JOLLA, June 5 — A research team at Scripps Research has identified a specific biochemical alteration that drives chronic inflammation in…
-
Scripps Team Finds Protein Switch Behind Alzheimer’s Brain Inflammation in Mice
A specific chemical alteration to a single protein may be the mechanism that sustains destructive brain inflammation in Alzheimer’s disease, according to…
-
Breakthrough Study Challenges Notion of Irreversible Paralysis and Nerve Damage
For many years the prevailing view held that once nerve pathways in the brain or spinal cord are cut, they cannot regenerate,…
-
Swiss Brain Implant Allows Paralyzed Man to Walk Naturally
On May 24, 2023, researchers in Switzerland announced a significant medical milestone. A man who had been paralyzed regained the ability to…
-
Swiss Brain Implants Restore Paralyzed Man’s Walking
May 24, 2023 — infopulsetoday.com — A groundbreaking medical breakthrough has been achieved by Swiss scientists, who have successfully enabled a paralyzed…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
How Major Medical Centers Partner With Tech Firms for Next-Gen Proton Therapy
-
FDA Denies Approval for Summit Therapeutics’ Ivonescimab in Lung Cancer
-
How will the next era of precision thoracic oncology change treatment choices for lung‑cancer patients?
-
FDA Approval Moves Astellas’ Padcev Into Curative Bladder Cancer Setting
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
Navigating 7% Mortgage Rates: Strategies for Buying a Home Now
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992






















